Abstract
Many Western countries have been affected by the outbreak of COVID-19.
Italy has been particularly hit at the beginning of the pandemic,
immediately after China. In Italy and elsewhere women seem to be less
affected then men by severe/fatal COVID-19 infection, regardless of
their age. Despite the evidence that women and men are different fort
this infection, very few studies consider different therapeutic
approaches for the two sexes. Undoubtedly, understanding the mechanisms
at the bases of these differences may help to find appropriate and sex
specific therapies. Here we consider that other mechanisms but estrogen
protection are involved. Several X-linked genes (such as ACE2) and
Y-linked genes (SRY, SOX9) may explain sex differences. Cardiovascular
comorbidities are among the major enhancers of virus lethality. In
addition, the number of sex-independent non-genetic factors that can
change susceptibility and mortality is enormous, and many other factors
are likely to be considered, including gender and cultural habits in
different countries.